This study systematically explored the expression pattern and clinical significance of SPOCK1 (SPARC/osteonectin, CWCV and Kazal-like domains proteoglycan 1) across multiple cancer types, with a particular focus on its role in breast cancer. This evidence concerns the gene SPARC and breast carcinoma.